search

MeSH 搜索器

Antineoplastic Agents, Immunological [Pharmacological Action]

树号: D000074322
MeSH 单一 ID: D000074322
进入的组:
  • abagovomab (补充概念*)
  • Abatacept (MeSH Term)
  • Ado-Trastuzumab Emtansine (MeSH Term)
  • Alemtuzumab (MeSH Term)
  • amivantamab-vmjw (补充概念*)
  • avelumab (补充概念*)
  • axicabtagene ciloleucel (补充概念*)
  • bavituximab (补充概念*)
  • bemarituzumab (补充概念*)
  • Bevacizumab (MeSH Term)
  • BI 836826 (补充概念*)
  • bivatuzumab mertansine (补充概念*)
  • BMS-936559 (补充概念*)
  • Brentuximab Vedotin (MeSH Term)
  • brexucabtagene autoleucel (补充概念*)
  • cantuzumab mertansine (补充概念*)
  • cemiplimab (补充概念*)
  • Cetuximab (MeSH Term)
  • conatumumab (补充概念*)
  • dacetuzumab (补充概念*)
  • DS-8273a (补充概念*)
  • durvalumab (补充概念*)
  • ecromeximab (补充概念*)
  • epratuzumab (补充概念*)
  • Gemtuzumab (MeSH Term)
  • glembatumumab vedotin (补充概念*)
  • idecabtagene vicleucel (补充概念*)
  • Inotuzumab Ozogamicin (MeSH Term)
  • intetumumab (补充概念*)
  • Ipilimumab (MeSH Term)
  • labetuzumab (补充概念*)
  • lintuzumab (补充概念*)
  • loncastuximab tesirine (补充概念*)
  • lorvotuzumab mertansine (补充概念*)
  • magrolimab (补充概念*)
  • necitumumab (补充概念*)
  • nimotuzumab (补充概念*)
  • Nivolumab (MeSH Term)
  • obinutuzumab (补充概念*)
  • oregovomab (补充概念*)
  • Panitumumab (MeSH Term)
  • patritumab deruxtecan (补充概念*)
  • pembrolizumab (补充概念*)
  • pertuzumab (补充概念*)
  • PF-06263507 (补充概念*)
  • pidilizumab (补充概念*)
  • rilotumumab (补充概念*)
  • rindopepimut (补充概念*)
  • Rituximab (MeSH Term)
  • sotorasib (补充概念*)
  • spartalizumab (补充概念*)
  • talimogene laherparepvec (补充概念*)
  • tisagenlecleucel (补充概念*)
  • tislelizumab (补充概念*)
  • tisotumab vedotin (补充概念*)
  • Trastuzumab (MeSH Term)
  • U3-1565 (补充概念*)
  • zalutumumab (补充概念*)
  • zanolimumab (补充概念*)

留言 (0)

沒有登入
gif